Tablets are used to treat certain bladder problems
New Delh: Drug maker Lupin on Monday said it has launched Mirabegron extended-release tablets (25 mg) in the US market.
The Mumbai-based drug maker has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement.
The company’s product is a generic equivalent of Astellas Pharma Global Development, Inc’s Myrbetriq extended-release tablets, it added.
Mirabegron extended-release tablets are used to treat certain bladder problems including overactive bladder.
Lupin shares were trading 3.38 per cent up at Rs1,599.35 apiece on the BSE.
